Makes photoresists and other chemical materials essential to semiconductor lithography.
Makes photoresists and other chemical materials essential to semiconductor lithography.
Photoresist is a consumable that chipmakers use up with every wafer, so sales follow wafers processed rather than equipment purchases, and a resist qualified into a fab's process tends to stay. A few Japanese makers dominate the advanced grades, and much of the company's sales are overseas.
In one line: A key photoresist supplier, like a JSR/Shin-Etsu peer.
Moat: wide (process know-how, IP / patents, customer qualification). Deep lithography-chemistry IP and long qualification cycles create high switching costs.
Headquarters: Kawasaki, Japan · Founded: 1940 · Employees: 2,132
Size Tokyo Ohka Kogyo (4186.T) is a Japan Materials company (Chemicals: Major Diversified) with a market value of $5.52B, the 223rd largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥7,264 on 18 Nov 2026.
Performance Over six months the shares fell 32.5%, against -5.1% for the median peer and -1.4% for the Japan market (cap-weighted) — 3rd lowest of 21 in its peer set.
Growth Revenue grew 24.0% over the last twelve months (peer median +6.2%); the operating margin is 21.8% (peer median 9.0%).
Valuation It trades at 19.4× forward earnings against a peer median of 14.5× (7th most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 21% a year for seven years (Req g). Recent delivered growth is +15%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.3 points above its cost of capital (14.1% WACC).
Next results Next results expected around 15 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥282B | ¥237B | ¥201B | ¥162B | ¥175B |
| Revenue growth | — | +18% | +24% | -8% | — |
| Gross profit | ¥109B | ¥86.2B | ¥70.4B | ¥55.5B | ¥61.0B |
| EBITDA | ¥72.5B | ¥56.2B | ¥41.4B | ¥30.4B | ¥36.9B |
| Net income | ¥43.4B | ¥33.3B | ¥22.7B | ¥12.7B | ¥19.7B |
| Free cash flow | n/a | ¥10.4B | ¥5.58B | ¥2.50B | ¥8.29B |
| Capital expenditure | n/a | ¥25.4B | ¥25.5B | ¥15.2B | ¥11.4B |
| Total debt | ¥26.2B | ¥26.5B | ¥10.5B | ¥10.5B | ¥10.2B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Tokyo Ohka Kogyo 4186.T | $5.52B | -32% | +24% | 22% | 19.4× | 20.8% |
| Shin-etsu Chemical 4063.T | $67.9B | -22% | +5% | 25% | 17.7× | 9.9% |
| Dow DOW | $22.0B | -15% | +4% | 5% | 14.3× | 4.4% |
| Fujifilm 4901.T | $27.9B | +16% | +7% | 10% | 15.8× | n/a |
| Sumitomo Chemical 4005.T | $4.95B | -21% | -2% | 5% | 7.1× | 1.7% |
| Dongjin Semichem 005290.KS | $1.28B | -42% | -4% | 16% | n/a | -2.4% |
| Merck KGaA MRK.DE | $71.3B | +16% | +1% | 19% | 17.4× | 7.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 4186.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -12.2% | -6.1% | 5th lowest of 21 |
| 6-month return | -32.5% | -5.1% | 3rd lowest of 21 |
| Distance from 52-week high | -43.8% | -23.1% | 6th lowest of 21 |
| Revenue growth (TTM) | +24.0% | +6.2% | 6th highest of 21 |
| Operating margin | 21.8% | 9.0% | 2nd highest of 21 |
| Forward P/E | 19.4× | 14.5× | 7th most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 20.8% | 9.1% | 3rd most demanding of 14 |
| Growth delivered (Del g) | +15.1% | +6.6% | 2nd highest of 14 |
| Hurdle (Req g minus delivered) | +5.8 pp | -0.3 pp | 7th most demanding of 14 |
| ROIC minus cost of capital | +3.3 pp | -1.7 pp | 5th highest of 21 |
| EV / EBITDA | 11.7× | 6.8× | 5th most expensive of 14 |
| Net debt / EBITDA | -0.5× | 1.8× | least indebted of 15 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Tokyo Ohka Kogyo 4186.T | Japan | $5.52B | -32% | +24% | 22% | 19.4× | 20.8% | +15.1% |
| Arkema AKE.PA | France | $4.83B | -3% | -2% | 5% | 13.3× | 12.3% | +2.8% |
| Perimeter Solutions PRM | United States | $4.82B | -12% | +31% | 15% | 17.7× | 40.1% | +14.0% |
| Kingfa Sci. & Tech 600143.SS | China | $4.64B | -33% | -1% | 3% | 22.5× | -1.9% | +13.3% |
| Ecopro 086520.KS | South Korea | $6.80B | -52% | -5% | 5% | 60.9× | n/a | n/a |
| Wacker Chemie WCH.DE | Germany | $4.42B | -18% | -5% | -1% | 33.1× | n/a | n/a |
| Avient AVNT | United States | $4.07B | +31% | +5% | 11% | 12.6× | 9.9% | +0.1% |
| Element Solutions ESI | United States | $7.90B | -20% | +40% | 14% | 15.6× | 17.6% | +6.6% |
| Mitsui Chemicals 4183.T | Japan | $3.85B | -21% | +6% | 7% | 9.7× | -0.3% | +6.6% |
| Hubei Xingfa Chemicals 600141.SS | China | $3.83B | -32% | +4% | 8% | 14.5× | n/a | n/a |
| Johnson Matthey JMAT.L | United Kingdom | $3.76B | +6% | +8% | 3% | 12.9× | 9.2% | -4.0% |
| Sasol Limited Sponsored ADR SSL | United States | $8.38B | -7% | +18% | 22% | 3.9× | n/a | n/a |
| Mitsubishi Chemical 4188.T | Japan | $8.75B | +3% | -1% | 8% | 9.0× | -1.0% | +2.6% |
| Kuraray 3405.T | Japan | $3.41B | +14% | +7% | 10% | 14.1× | -5.0% | +8.3% |
| Peric Special Gases 688146.SS | China | $8.93B | +40% | +75% | 19% | 60.9× | 49.3% | +13.1% |
| Solstice Advanced Materials SOLS | United States | $10.3B | -22% | +3% | 17% | 20.2× | 2.4% | +2.7% |
| CES Energy Solutions CEU.TO | Canada | $2.92B | +5% | +17% | 11% | 13.5× | 9.1% | +22.9% |
| Evonik Industries EVK.DE | Germany | $11.1B | +27% | +2% | 10% | 12.1× | -5.6% | +2.9% |
| Grandit 688549.SS | China | $2.66B | -7% | +40% | -1% | n/a | n/a | n/a |
| Aether Industries AETHER.NS | India | $2.34B | +50% | +31% | 25% | 76.6× | n/a | n/a |
| Nippon Shokubai 4114.T | Japan | $2.24B | +16% | +8% | 6% | 17.4× | n/a | n/a |